Project Grant R01DA062443
Award Date 9/1/25
Completion Date 7/31/30
Dollars Obligated $687K
Federal Agency
Federal Grant Program
Assistance Type
Project Grant
Place of Performance
Charleston, SC 29425, USA
Similar Awards
- This $668,110 Project Grant awarded by the National Institute on Drug Abuse (NIDA) under the Drug Use and Addiction Research Programs (CFDA 93.279) will fund the development and acceptability testing of a technology-based intervention to reduce cannabis misuse among college students. The project aims to refine an existing intervention that provides information on cannabis products, marketing, laws, and risks to increase young adults' cannabis literacy. The research will involve focus groups with...
- This $507,000.00 federal Project Grant award from the National Institute on Drug Abuse (NIDA), under the Drug Use and Addiction Research Programs (CFDA 93.279), supports research at the Icahn School of Medicine at Mount Sinai to investigate the epigenetic mechanisms underlying cannabis use disorder. The project, running from September 1, 2025 to May 31, 2030, aims to leverage a translational animal model of voluntary THC consumption to study sex differences and individual variability in...
- The National Institute on Drug Abuse (NIDA), part of the National Institutes of Health, awarded a $334,343 Project Grant under the Drug Use and Addiction Research Programs (CFDA 93.279) to Syncanica Bio, Inc. on June 15, 2025. The goal of this award is to develop and market a synthetic analog of 8,9-dihydrocannabidiol (H2CBD) as a therapeutic agent for the treatment of substance use disorder, a significant public health crisis. This builds upon Syncanica Bio's existing research on the...
- This federal Project Grant award of $385,638 was provided by the National Institute on Drug Abuse (NIDA), part of the National Institutes of Health, under the Drug Use and Addiction Research Programs (CFDA 93.279). The purpose of the grant is to conduct research on the neurobehavioral consequences of chronic exposure to synthetic cannabinoids, also known as "synthetic marijuana", across different stages of lifespan development and between sexes. The research aims to elucidate the...
- The National Institute on Drug Abuse (NIDA) has awarded a $159,139 Project Grant to George Washington University (GWU) under the Drug Use and Addiction Research Programs (CFDA 93.279). The grant, awarded on August 15, 2025, will support research on the "Impact of Derived Psychoactive Cannabis Product Marketing on Perceptions and Use Among Young Adults." This project aims to investigate the effects of the marketing and availability of cannabis products on usage patterns and...
- The National Institute on Drug Abuse (NIDA), through the Drug Use and Addiction Research Programs (CFDA 93.279), has awarded a $684,694 Cooperative Agreement to New York University (NYU) to develop and evaluate a novel home-based intervention combining transcranial direct current stimulation (tDCS) with mindfulness meditation for the treatment of cannabis use disorder (CUD). The project, titled "Telehealth-Delivered tDCS for Cannabis Addiction Recovery: The C.A.R.E.S. (Cannabis Addiction...
- The National Institute on Drug Abuse (NIDA), part of the National Institutes of Health, awarded a $639,920 project grant under the Drug Use and Addiction Research Programs (CFDA 93.279) to the Board of Regents of the Nevada System of Higher Education, operating through the University of Nevada, Reno. The grant, which runs from September 15, 2025 to May 31, 2030, will fund a human laboratory study to examine the influence of "natural" cigarillo descriptors on expectancies, subjective...
- This federal Project Grant award for $395,995.00 was provided by the National Institute on Drug Abuse (NIDA), part of the National Institutes of Health (NIH), under the Drug Use and Addiction Research Programs (CFDA 93.279). The grant will fund a 5-year prospective study to investigate the bidirectional relationship between cannabis use, sleep, and the hypothalamic-pituitary-adrenal (HPA) axis in 60 participants aged 21-29 years, including healthy controls, moderate cannabis users, and those...
- This federal Project Grant award of $429,000.00 was provided by the National Institute on Drug Abuse (NIDA), which falls under the Drug Use and Addiction Research Programs (CFDA 93.279), to Oregon Health & Science University (OHSU). The objective of this project is to develop and apply new tools to precisely manipulate the effects of tetrahydrocannabinol (THC), the main psychoactive compound in marijuana, on the brain's reward circuitry. Specifically, the researchers have created...
- The National Institute on Drug Abuse (NIDA) awarded a $1,383,618 Project Grant under the Drug Use and Addiction Research Programs (CFDA 93.279) to The Johns Hopkins University to study the adverse effects of cannabis (primarily delta-9-tetrahydrocannabinol or THC) on prefrontal cortex maturation and cognitive function during adolescence. The project aims to investigate how microglia, a type of immune cell in the brain, mediate the impact of adolescent THC exposure on the prefrontal cortex,...